• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

Committee finds Fort Detrick biocontainment labs not a threat
by Ted Purlain on March 11, 2010

The National Research Council has released a report at Congress' behest that finds several problems in the U.S. Army's environmental impact statement for its expansion of Fort Detrick's bicontainment laboratories.

English man pleads guilty to ricin possession
by Ted Purlain on March 9, 2010

A white supremacist in England has pleaded guilty to the production of the deadly poison ricin for use in acts of terrorism.

Missouri National Guard receives biothreat training
by Ted Purlain on March 8, 2010

Missouri National Guard members at Fort Leonard Wood were trained this weekend on biological, chemical and nuclear detection equipment.

Panel questions risk of Fort Detrick lab
by Ted Purlain on March 5, 2010

A National Academy of Sciences panel has revealed that the U.S. Army failed to analyze fully the public exposure risks of deadly pathogens from a Fort Detrick biodefense laboratory.

Anthrax scare shuts down Georgia high school
by Ted Purlain on March 4, 2010

Georgia's Gilmer County faced an anthrax scare for the second straight day on Wednesday, when an envelope containing a suspicious white powder was found at Gilmer County High School in Ellijay, Georgia.

India deploys CBRN squad to hockey World Cup
by Ted Purlain on March 3, 2010

India has deployed approximately 100 personnel from its National Disaster Response Force to guard the National Stadium against probable biological, chemical or nuclear disasters as it hots the hockey World Cup.

Experts respond to Harvard anthrax response study
by Ted Purlain on March 2, 2010

Universal Detection Technology has responded to a recent Harvard School of Public Health poll that found 39 percent of Americans facing a significant anthrax threat would delay taking prophylactic antibiotics.

Bioattack simulated in Tennessee
by Ted Purlain on February 25, 2010

Eighteen members of the Army National Guard and four members of the Air Force National Guard used Shelbyville, Tenn.'s Calsonic Arena this week to stage a training exercise simulating a biological or chemical attack.

Mich. police chief joins Emergent BioSolutions Inc.
by Ted Purlain on February 24, 2010

Lansing, Michigan police chief Mark Alley has announced that he will retire within the month to take a new position at Emergent BioSolutions Inc. as the company's senior director of risk management.

Anthrax death toll in Scotland rises
by Ted Purlain on February 23, 2010

The death toll in Scotland for drug users infected by anthrax through intravenous injections has risen to 10, health officials have said.

Europe needs generic response plan to pandemic threats, expert says
by Ted Purlain on February 22, 2010

Disease specific plans utilized by most European countries could cost precious time and resources, a study about gaps in pandemic preparedness has revealed.

Camber Corp. to provide Edgewood Chemical Biological Center with support services
by Ted Purlain on February 18, 2010

The U.S. Army's Edgewood Chemical Biological Center has selected Camber Corp. to provide it with engineering, research and technology support services.

Expert says bioattack unlikely
by Ted Purlain on February 17, 2010

Experts have said that a biological or nuclear attack on the United States by terrorist remains the nation's greatest threat but is unlikely to occur.

WellCrown to distribute UDT's biothreat monitors in Asia
by Ted Purlain on February 16, 2010

Universal Detection Technology will allow WellCrown to act as UDT's sole agent and distributor in Malaysia for its early-warning monitoring technologies that protects against bioterrorism.

N.H. anthrax victim walking, remains hospitalized
by Ted Purlain on February 15, 2010

The New Hampshire woman who contracted a rare form of anthrax two months ago is now able to get up and walk around, health officials have announced, but will remain hospitalized for some time

Conferences will review U.S.'s ability to reduce biothreat
by Ted Purlain on February 10, 2010

A pair of conferences over the next few weeks will enact a comprehensive review of the United States' ability to reduce the impact of a biological weapons attack.

Cell phones could aid in attack detection
by Ted Purlain on February 8, 2010

Cell phones could soon be used as nodes as part of a wide reaching chemical weapon sensor network.

Missile test-fired by Iran has potential bioweapon capabilities
by Ted Purlain on February 4, 2010

Iran has announced the successful test firing of a new satellite-carrying rocket containing an "experimental capsule" with live species inside that has raised the spectre of potential biological or chemical attacks.

White powder sent to U.S. federal building
by Ted Purlain on February 4, 2010

Authorities have said that seven people in a U.S. federal building in downtown Manhattan were exposed to a suspicious white powde

Study begins to find more effective manner of fighting smallpox
by Ted Purlain on February 3, 2010

A more effective manner of administering an investigational vaccine for smallpox will be studied by scientists at Saint Louis University's Center for Vaccine Development in a study funded by the National Institute of Health.

Commission gives U.S. a failing grade for biopreparedness
by Ted Purlain on January 27, 2010

A report card released today by the bipartisan Commisson on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism has turned a critical eye to the preparedness by the United States for a bioattack.

Rep. Loretta Sanchez named new head of terrorism, unconventional threats subcommittee
by Ted Purlain on January 25, 2010

Rep. Loretta Sanchez, D-Calif., has been selected as the new head of the U.S. House Armed Services terrorism, unconventional threats and capabilities subcommittee.

SIGA Technologies takes part in Israel's simulated bioattack
by Ted Purlain on January 21, 2010

Representatives from SIGA Technologies took part in Israel's recent "Operation Orange Flame 4" biological defense drill conducted by the Defense Ministry and Health Ministry in conjunction with the Israel Defense Forces Home Front Command.

Anthrax death from heroin reported in Germany
by Ted Purlain on January 18, 2010

Following the deaths of seven heroin users and infections of 14 by anthrax in Scotland, fears have begin to rise in Germany following a fatal case of anthrax in a 24-year-old male injecting drug user.

Subject: BPW - R. Don Elsey joins MdBio Foundation's board of directors
by Ted Purlain on January 12, 2010

Emergent BioSolutions Inc.'s R. Don Elsey, chief financial officer and senior vice president of finance and administration, has joined the MdBio Foundation's board of directors.

HIV infected Mich. man hit with bioterror charge for biting another man
by Ted Purlain on January 4, 2010

Bioterrorism charges were leveled against a Michigan man who, in the course of a fight with his neighbor, bit him. The biter in the case, authorities learned, was HIV positive.

Louisiana begins drawing up plans for bioattack treatments
by Ted Purlain on December 28, 2009

Guidelines to specify which patients will receive access to lifesaving treatments in the event of a bioterrorist attack, severe pandemic or natural disaster that overwhelms the medical system are being developed by Louisiana health professionals.

Barry Kellman addresses the House International Affairs Subcommittee on Terrorism & Nonproliferation
by Ted Purlain on December 18, 2009

Following his staff briefing at the House International Affairs Subcommittee on Terrorism & Nonproliferation yesterday, Barry Kellman, president of the International Security & Biopolicy Institute, spoke with BioPrepWatch.

Positive results announced for Restanza in treatment of inhaled tularemia
by Ted Purlain on December 17, 2009

Positive top-line results have been announced by Advanced Life Sciences Holdings, Inc., for its once-a-day, oral antibiotic Restanza to treat inhaled lethal doses of tularemia.

Israel's Home Front Command simulates CBRN strike
by Ted Purlain on December 15, 2009

Israel's Home Front Command has begun joint exercises with Magen David Adom and the Shaare Tzedek Medical Center to prepare for chemical, biological, radiological and nuclear missile attacks.

Researchers given contract to expand pathogen database
by Ted Purlain on December 11, 2009

A five year, $14. million contract has been awarded to researchers from the University of Georgia and the University of Pennsylvania from the National Institute of Allergy and Infectious Diseases.

New method of destruction for chemical weapon stockpiles advanced
by Ted Purlain on December 9, 2009

A plan to use explosives to eliminate chemical weapons stockpiled in Colorado and Kentucky has been floated by army officials, arguing that it would improve safety while prevent lags in the nation's weapons destruction schedule.

Homeland Security to study dispersion of biological weapons in Boston subway
by Ted Purlain on December 4, 2009

The U.S. Homeland Security Department will release harmless gases and dye tracers into Boston's subway system next week to study the circulation of airborne contaminants through public transit networks in the event of a biological or chemical attack.

Bioterror alert raised in Uganda
by Ted Purlain on December 3, 2009

Uganda's minister of health has announced that the nation's government has raised a full alert through its national disease surveillance network for any possible biological or chemical terrorist attack.

Obama administration announces major review of public health defenses
by Ted Purlain on December 2, 2009

Plans have been announced by a top Obama administration official to proceed with a major review of the federal government's policies for developing public health defenses.

European Defense Agency announces plans for biological explosives disposal training
by Ted Purlain on December 1, 2009

Plans to organize a biological, chemical and radiological explosives ordnance disposal training exercise have been announced by the European Defense Agency.

Human Genome Sciences, Inc. receives approval for anthrax treatment
by Ted Purlain on November 19, 2009

A Complete Response Letter has been sent to Human Genome Sciences, Inc., from the U.S. Food and Drug Administration about HGS' request for the approval of its treatment for inhalational anthrax.

Canadian pathogen labs found to be struggling to keep track of their pathogens
by Ted Purlain on November 17, 2009

A recent audit has shown that Canadian government labs handling samples of swine flu and other viruses and bacteria are struggling to keep track of their pathogens.

Boston biodefense complex faces legal challenges
by Ted Purlain on November 16, 2009

A $198 million Boston University Medical Center biological defense laboratory complex's opening has been blocked by federal and state lawsuits brought by the public.

DARPA seeks proposals to improve bio-threat detectors
by Ted Purlain on November 12, 2009

The Defense Advanced Research Projects Agency is requesting proposals for a device that would enable faster, more accurate detection of a broad range of biological agents, writes Katie Drummond of Wired.com.

SRI International opens research center in Virginia
by Ted Purlain on November 12, 2009

RI International opened a new facility for its Center for Advanced Drug Research, where scientists will work on developing vaccines, more quickly diagnosing infections and developing new treatments.

Former Homeland Security secretary named Global Security leader at national lab
by Ted Purlain on November 11, 2009

LIVERMORE, Calif. — Penrose. C. “Parney” Albright, former assistant secretary at the Department of Homeland Security, has been named the principal associate director of Global Security at Lawrence Livermore National Laboratory.

University of Illinois to develop antibiotics against potential bioterrorism agents
by Ted Purlain on November 11, 2009

Researchers at the University of Illinois at Chicago have received a $4 million federal grant to develop new antibiotics to treat anthrax, tularemia and plague, the university announced Nov. 10.

Tara O’Toole to lead DHS’ science and technology directorate
by Ted Purlain on November 6, 2009

WASHINGTON, D.C. — The U.S. Senate confirmed Tara O’Toole to be undersecretary of the science and technology directorate at the Department of Homeland Security on Nov. 5.

NIAID awards Northrop Grumman for bioinformatics resource centers
by Ted Purlain on November 5, 2009

RESTON, Va. — Northrop Grumman Corp. has been awarded a contract by the National Institute of Allergy and Infectious Diseases to create a resource that supports research of pathogenic viruses.

Diatherix CEO calls biodefense, biotechnology conference ‘timely’
by Ted Purlain on November 4, 2009

HUNTSVILLE, Ala. — Diatherix Laboratories Inc. presented at the Michigan Security Network Homeland Security Market Leadership Conference on Nov. 4 in Dearborn, Mich.

Smiths Detection awarded TSA contract for portable liquid scanners
by Ted Purlain on November 2, 2009

PINE BROOK, N.J. — Smiths Detection announced a $21.9 million order from the Transportation Security Administration to supply portable liquid detection scanners for its Bottle Liquid Scanner program.

GSN names winners in 2009 Homeland Security Awards
by Ted Purlain on October 29, 2009

NEW YORK — GSN: Government Security News announced 38 winners of its 2009 Homeland Security Awards on Oct. 29.

Animals now picking up bugs from people, study shows
by Ted Purlain on October 27, 2009

Globalization and industrialization are causing diseases to spread from humans to animals, a study released Oct. 26 has shown.

N.H. agencies take part in terror event drill
by Ted Purlain on October 20, 2009

The New Hampshire Department of Human Services asked all health regions to respond to a training scenario where there was a deliberate terrorist release of the biological agent anthrax.

Biosecurity panel’s findings heading to Obama
by Ted Purlain on October 16, 2009

WASHINGTON — The findings of a high-level panel that examined strategies to boost security at laboratories conducting research with dangerous diseases will be submitted to U.S. President Barack Obama soon.

Emergent BioSolutions submits development plan for anthrax vaccine
by Ted Purlain on September 14, 2009

ROCKVILLE, Md -- Emergent BioSolutions Inc. has submitted a development plan to the FDA for its Recombinant Protective Antigen (rPA) anthrax vaccine candidate.

DOR BioPharma awarded $500,000 for clinical study
by Ted Purlain on September 14, 2009

PRINCETON, N.J. -- The NIH has awarded DOR BioPharma a $500,000 Small Business Innovation Research grant to support a clinical evlauat

Emergent BioSolutions recognized as best security organization
by Ted Purlain on September 14, 2009

LANSING, Mich -- Security magazine has named Emergent BioSolutions to its "Security 500: The Biggest and Best Security Organizations." This is first time the magazine has honored Emergent.

Emergent BioSolutions CEO named Ernst & Young Entrepreneur of the Year
by Ted Purlain on June 18, 2009

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced June 18, 2009, that Fuad El-Hibri, its chairman and CEO, received the Ernst & Young Entrepreneur of the Year 2009 Award in the Technology category in Greater Washington.

Emergent BioSolutions, FDA review strategy for recombinant anthrax vaccine
by Ted Purlain on June 11, 2009

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced June 11, 2009, that it has met with the U.S. Food and Drug Administration to review its regulatory strategy for the development of its recombinant anthrax vaccine.

Emergent BioSolutions, Ninebio Sdn. Bhd. announce joint venture In Malaysia
by Ted Purlain on January 24, 2008

ROCKVILLE, Md., and PUTRAJAYA, Malaysia — Emergent BioSolutions and Ninebio Sdn. Bhd. announced the formation of a joint venture in Malaysia that will focus on creating critical biologics infrastructure and supplying biodefense countermeasures.

Emergent BioSolutions appoints Ronald Richard to board of directors
by Ted Purlain on January 26, 2005

GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced the appointment of Ronald Richard to its six-person board of directors.